Sign in
4

Changes in Ownership

ROCKET PHARMACEUTICALS, INC. Filed Acc 0001140361-25-005846

General Counsel sold 3,222 shares at $10.58 ($34,089)

From the SEC's structured data for this filing

Trades in this filing

Wilson Martin · General Counsel

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-02-21 Sale : show line 1 in the form −3,222 $10.58 $34,089 150,696 D
Open-market sales · 3,222 sh · avg $10.58 · $34,089
Loading xslF345X05/form4.xml…